Drawing for FLARE PHARM

USPTO serial 88940337

FLARE PHARM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLOHM, LINDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FLARE PHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 S. JACKSON STREET, SUITE 200GLENDALE, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements consisting primarily of cannabidiol oil derived from industrial hemp; edible hemp oil with naturally occurring cannabidiol (CBD) for use as a dietary supplement; hemp oil with naturally occurring cannabidiol (CBD) as a nutritional supplement; Dietary and nutritional supplements comprised of hemp with naturally occuring cannabidiol (CBD); hemp protein powder with naturally occuring cannabidiol (CBD) for use as a nutritional supplement; hemp protein with naturally occuring cannabidiol (CBD) for use as a nutritional supplement in various powered and ready-to-drink beverages; meal replacement powders comprised of hemp for medical purposes; meal replacement bars comprised of hemp for medical purposes; meal replacement drink mixes comprised of hemp for medical purposes; hemp-based dietary supplement drink mixes with naturally occuring cannabidiol (CBD); hemp-based nutraceuticals with naturally occuring cannabidiol (CBD) for use as a dietary supplement; hemp-based topical creams, gels, salves, sprays, balms and ointments for analgesic purposes; nutrition supplements comprised of hemp with naturally occuring cannabidiol (CBD) in drop form, capsule form, and in liquid form; edible hemp oil with naturally occuring cannabidiol (CBD) for use as a dietary supplement; hemp oil with naturally occuring cannabidiol (CBD) as a nutritional supplement; Dietary and nutritional supplements in drop form, capsule form, pill form, liquid form; protein powders and protein bars for use as dietary and nutritional supplements; nutraceuticals for use as a dietary supplement; drink mixes for nutritional supplement purposes; medicated topical creams, gels, salves, sprays, balms, poultice, and ointments; edible oil for use as a nutritional supplement; Dietary and nutritional supplements for humans and animals containing hemp or hemp derivatives, all of the foregoing containing hemp ingredients having a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis and containing not more than trace amounts of naturally occurring cannabidiolACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 3, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 3, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2021EX1GSOU EXTENSION 1 GRANTED—
May 31, 2021EXT1SOU EXTENSION 1 FILED—
May 31, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 1, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 6, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 31, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2020DOCKASSIGNED TO EXAMINER—
Jun 22, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance